ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36837
-0.06%
Bitcoin
64,413.43
0.65%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) News

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HEMO
DateTimeSourceHeadlineSymbolCompany
04/25/20246:19AMAlliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
04/25/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
03/28/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
02/29/20248:04AMAlliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
02/29/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
02/16/20245:27AMAlliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
02/16/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
02/14/20244:14AMAlliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
02/14/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
02/09/20244:00AMAlliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
02/09/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
02/02/20244:44AMAlliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
02/02/20241:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
01/16/20245:13AMAlliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
01/16/20241:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC Submission of Complete Response to Clinical HoldLSE:HEMOHemogenyx Pharmaceuticals Plc
01/08/20244:56AMAlliance NewsAlliance NewsHemogenyx Pharmaceuticals completes process qualification runLSE:HEMOHemogenyx Pharmaceuticals Plc
01/08/20241:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process Qualification Run CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
11/28/202310:53AMAlliance NewsAlliance NewsTRADING UPDATES: Upland Resources completes technical study at SarawakLSE:HEMOHemogenyx Pharmaceuticals Plc
11/28/20236:19AMUK RegulatoryHemogenyx Pharmaceuticals PLC Placing to Raise GBP534,375LSE:HEMOHemogenyx Pharmaceuticals Plc
11/27/20234:52AMAlliance NewsAlliance NewsHemogenyx shares up as says CBR platform a potential cancer treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
11/27/20231:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC CBR Expanded to Treatment of CancerLSE:HEMOHemogenyx Pharmaceuticals Plc
11/15/20239:43AMAlliance NewsAlliance NewsHemogenyx Pharmaceuticals completes lentivirus re-manufactureLSE:HEMOHemogenyx Pharmaceuticals Plc
11/15/20231:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC Lentivirus Re-manufacturing CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
10/31/20232:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
09/28/20238:24AMAlliance NewsAlliance NewsEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensLSE:HEMOHemogenyx Pharmaceuticals Plc
09/28/20236:28AMUK RegulatoryHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
09/18/20238:37AMAlliance NewsAlliance NewsTRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells QuestersLSE:HEMOHemogenyx Pharmaceuticals Plc
09/18/20231:00AMUK RegulatoryHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
09/14/20238:31AMAlliance NewsAlliance NewsHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift planLSE:HEMOHemogenyx Pharmaceuticals Plc
09/14/20233:11AMDow Jones NewsHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsLSE:HEMOHemogenyx Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HEMO

Your Recent History

USOTC
CYDY
CytoDyn (QB)
USOTC
VPLM
Voip Pal Com (QB)
COIN
SHIBUSD
SHIBA INU
NASDAQ
COOP
Mr Cooper
USOTC
SPZI
Spooz (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IFUS
Impact Fusion (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
TGLO
TheGlobe com (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
NASDAQ
LWLG
Lightwave Logic
NASDAQ
DJT
Trump Media and Technology
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
AGBA
AGBA
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved